Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
search
Join
FREE
This site is intended for healthcare professionals
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Congress Hub
Toolkit
Paediatric Growth Calculator
DVT Risk Calculator
Due Date Calculator
Mean Arterial Pressure (MAP) Calculator
BMI Calculator
Collaborate
About
EQOH
Careers
Contact Us
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Work with Us
EMJ Interactive
EMJ GOLD
CME
Join
FREE
Search type
Keyword
Author
Edition
European
US
Neurology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Interviews
Podcasts
Videos & Webinars
News
Infographics
Society updates
Submit A Paper
ALS Progression Linked to Later Salivary Melatonin Onset
October 2026
Melatonin onset is earlier in early ALS, and later onset has been linked to faster decline. See why larger studies are needed.
Read more
29 Oct 2026
ALS Progression Linked to Later Salivary Melatonin Onset
Melatonin onset is earlier in early ALS, and later onset has been linked to faster decline. See why larger studies are needed.
28 Oct 2026
Inflammatory Bowel Disease Risk After Anti-CD20 Treatment in MS
Rituximab treatment in multiple sclerosis has been associated with a higher risk of inflammatory bowel disease than other modern therapies.
26 Oct 2026
What is the Link Between PMOS and Alzheimer’s Disease?
Any link between PMOS and Alzheimer’s disease is likely mediated by metabolic comorbidities, a new review suggests. Find out what it means for care.
24 Oct 2026
Artificial Intelligence Advances CNS Autoimmune Disease Care
Artificial intelligence may improve diagnosis, monitoring and risk stratification in CNS autoimmune diseases.
23 Oct 2026
AI Models Show Promise in Alzheimer's Classification
Machine-learning models using routine clinical data achieved up to 88.1% accuracy in classifying cognitive impairment, but require external validation.
23 Oct 2026
Cumulative and Recent Cannabis Use Linked to Poorer Sleep Quality
Cannabis use has been linked to poorer objective sleep quality in middle-aged adults, although no association has been found with self-reported sleep.
23 Oct 2026
Machine Learning Shows Promise for Alzheimer’s Classification
Machine learning for Alzheimer’s disease classification achieved up to 88.1% accuracy using clinical data, but external validation remains necessary.
22 Oct 2026
Ultraprocessed Food Linked to Vascular Brain Injury in Midlife
Higher ultraprocessed food intake has been linked to greater adiposity and vascular brain injury in middle-aged adults.
Loading posts...
1
2
3
…
75
Next »
We’ve noticed you’re accessing
from
North/South America.
View
View